Author:
Zhang Jingwen,Sikka Sakshi,Siveen Kodappully S.,Lee Jong Hyun,Um Jae-Young,Kumar Alan Prem,Chinnathambi Arunachalam,Alharbi Sulaiman Ali,Basappa ,Rangappa Kanchugarakoppal S.,Sethi Gautam,Ahn Kwang Seok
Funder
National Medical Research Council
NUHS Bench-to-Bedside-to-Product
National Research Foundation of Korea
Department of Science and Technology, Government of Kerala
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Biochemistry, medical,Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology
Reference36 articles.
1. Pouresmaeili F, Hosseini SJ, Farzaneh F et al (2014) Evaluation of environmental risk factors for prostate cancer in a population of Iranian patients. Asian Pac J Cancer Prev 15:10603–10605
2. Gerber L, Banez LL, Freedland SJ (2010) Defining and treating high-risk prostate cancer: can we do better? Eur Urol 58:8–9
3. Sharifi N, Gulley JL, Dahut WL (2005) Androgen deprivation therapy for prostate cancer. Jama 294:238–244
4. Mukherji D, Omlin A, Pezaro C, Shamseddine A, de Bono J (2014) Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics. Cancer Metastasis Rev 33:555–566
5. Heidegger I, Massoner P, Eder IE et al (2013) Novel therapeutic approaches for the treatment of castration-resistant prostate cancer. J Steroid Biochem Mol Biol 138:248–256
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献